Back
Jack Nathan Medical Quote, Financials, Valuation and Earnings
The #1 Energy Passive Income Investment for 2023The #1 Energy Passive Income Investment for 2024
CLICK HERE TO FIND OUT WHAT IT IS.
Buy
61
JNH.V
Jack Nathan Medical
Last Price:
0.03
Seasonality Move:
-8.38%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MOREJack Nathan Medical Price Quote
$0.03
Jack Nathan Medical Key Stats
Buy
61
Jack Nathan Medical (JNH.V)
is a Buy
Day range:
$0.03 - $0.03
52-week range:
$0.02 - $0.08
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
0
Avg. volume:
35.4K
1-year change:
-37.5%
Market cap:
$2.2M
Revenue:
$15.5M
EPS:
$-0.08
How Much Does Jack Nathan Medical Make?
-
How Much Are Jack Nathan Medical's Sales Annually?
JNH.V Revenues are $15.5M -
How Much Profit Does Jack Nathan Medical's Make A Year?
JNH.V net income is -$7.1M
Is Jack Nathan Medical Growing As A Company?
-
What Is Jack Nathan Medical's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.15% -
What Is Jack Nathan Medical's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Jack Nathan Medical Stock Price Performance
-
Did Jack Nathan Medical Stock Go Up Last Month?
Jack Nathan Medical share price went up by 0% last month -
Did JNH.V's Share Price Rise Over The Last Year?
JNH.V share price fell by -37.5% over the past 1 year
What Is Jack Nathan Medical 52-Week High & Low?
-
What Is Jack Nathan Medical’s 52-Week High Share Price?
Jack Nathan Medical has traded as high as $0.08 over the past 52 weeks -
What Is Jack Nathan Medical’s 52-Week Low Share Price?
Jack Nathan Medical has traded as low as $0.02 over the past 52 weeks
Jack Nathan Medical Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Jack Nathan Medical?
-
How Much Debt Does Jack Nathan Medical Have?
Total long term debt quarterly is $11.1M -
How Much Cash Does Jack Nathan Medical Have?
Cash and short term investments quarterly total is $5.3M -
What Is Jack Nathan Medical’s Book Value Per Share?
Book value per share is -0.06
Is Jack Nathan Medical Cash Flow Positive?
-
What Is JNH.V Cash Flow From Operations?
Cash flow from operations (TTM) is -$4.5M -
What Is Jack Nathan Medical’s Cash Flow From Financing?
Cash flow from financing (TTM) is $12.7M -
What Is Jack Nathan Medical’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$4.5M
Jack Nathan Medical Return On Invested Capital
-
Is Management Doing A Good Job?
JNH.V return on invested capital is -130.72% -
What Is Jack Nathan Medical Return On Assets?
ROA measures how assets are converting to revenues and is -88.15% -
What Is JNH.V Return On Equity?
ROE is a measure of profitability and is 0%
Jack Nathan Medical Earnings Date & Stock Price
-
What Is Jack Nathan Medical's Stock Price Today?
A single share of JNH.V can be purchased today for 0.03 -
What Is Jack Nathan Medical’s Stock Symbol?
Jack Nathan Medical trades on the tsxv under the ticker symbol: JNH.V -
When Is Jack Nathan Medical’s Next Earnings Date?
The next quarterly earnings date for Jack Nathan Medical is scheduled on December 11, 2024 -
When Is JNH.V's next ex-dividend date?
Jack Nathan Medical's next ex-dividend date is December 11, 2024 -
How To Buy Jack Nathan Medical Stock?
You can buy Jack Nathan Medical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Jack Nathan Medical Competitors
-
Who Are Jack Nathan Medical's Competitors?
Below is a list of companies who compete with Jack Nathan Medical or are related in some way:
Jack Nathan Medical Dividend Yield
-
What Is JNH.V Dividend Yield?
Jack Nathan Medical’s dividend yield currently is 0% -
What Is Jack Nathan Medical’s Payout Ratio?
Jack Nathan Medical’s payout ratio is 0% -
When Did Jack Nathan Medical Last Pay A Dividend?
The latest dividend pay date is December 11, 2024 -
What Is Jack Nathan Medical’s Dividend Per Share?
Jack Nathan Medical pays a dividend of $0.00 per share
Jack Nathan Medical Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 0% |
| Revenue: | 15.47% | 0% |
Analyst Recommendations
| Buy Recommendations: | 0 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 0.00 |
| Downside from Last Price: | -100% |
Major Shareholders
Data Unavailable